Insider Trading Alert - HFWA, AMSG And MHR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 4, 2014, 88 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $555.68 to $8,275,700.00.

Highlighted Stocks Traded by Insiders:

Heritage Financial (HFWA) - FREE Research Report

Altom Rhoda L, who is Director at Heritage Financial, bought 585 shares at $17.09 on Dec. 4, 2014. Following this transaction, the Director owned 3,159 shares meaning that the stake was boosted by 22.73% with the 585-share transaction.

The shares most recently traded at $17.20, up $0.11, or 0.62% since the insider transaction. Historical insider transactions for Heritage Financial go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 1,528
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 1,528
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 1,528

The average volume for Heritage Financial has been 73,400 shares per day over the past 30 days. Heritage Financial has a market cap of $513.1 million and is part of the financial sector and banking industry. Shares are up 0.06% year-to-date as of the close of trading on Wednesday.

Heritage Financial Corporation operates as the bank holding company for Heritage Bank that provides various financial services to small businesses and general public. The stock currently has a dividend yield of 2.12%. The company has a P/E ratio of 27.8. Currently, there are 6 analysts who rate Heritage Financial a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HFWA - FREE

TheStreet Quant Ratings rates Heritage Financial as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Heritage Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Amsurg (AMSG) - FREE Research Report

Lavender Kevin P, who is Director at Amsurg, sold 3,000 shares at $51.51 on Dec. 4, 2014. Following this transaction, the Director owned 10,853 shares meaning that the stake was reduced by 21.66% with the 3,000-share transaction.

The shares most recently traded at $50.50, down $1.01, or 2% since the insider transaction. Historical insider transactions for Amsurg go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares sold: 3,000

The average volume for Amsurg has been 401,100 shares per day over the past 30 days. Amsurg has a market cap of $2.4 billion and is part of the health care sector and health services industry. Shares are up 11.17% year-to-date as of the close of trading on Wednesday.

AmSurg Corp., through its subsidiaries, acquires, develops, and operates ambulatory surgery centers (ASC) in partnership with physicians in the United States. The company has a P/E ratio of 38.5. Currently, there are 6 analysts who rate Amsurg a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMSG - FREE

TheStreet Quant Ratings rates Amsurg as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Amsurg Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Magnum Hunter Resources Corporation (MHR) - FREE Research Report

Dawson R Glenn, who is Evp at Magnum Hunter Resources Corporation, sold 180,836 shares at $3.92 on Dec. 4, 2014. Following this transaction, the Evp owned 115,001 shares meaning that the stake was reduced by 61.13% with the 180,836-share transaction.

The shares most recently traded at $3.91, down $0.01, or 0.23% since the insider transaction. Historical insider transactions for Magnum Hunter Resources Corporation go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 741,123
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 973,567
  • 24-Week # shares bought: 78,500
  • 24-Week # shares sold: 998,967

The average volume for Magnum Hunter Resources Corporation has been 6.5 million shares per day over the past 30 days. Magnum Hunter Resources Corporation has a market cap of $797.6 million and is part of the basic materials sector and energy industry. Shares are down 42.95% year-to-date as of the close of trading on Wednesday.

Magnum Hunter Resources Corporation, an independent oil and natural gas company, explores for, exploits, acquires, develops, and produces crude oil, natural gas, and natural gas liquid resources in the United States. Currently, there are 9 analysts who rate Magnum Hunter Resources Corporation a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MHR - FREE

TheStreet Quant Ratings rates Magnum Hunter Resources Corporation as a sell. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, weak operating cash flow, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Magnum Hunter Resources Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Retreat as U.S.-China Trade War Intensifies

Global Stocks Retreat as U.S.-China Trade War Intensifies

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods